PAR PHARM FDA Approval ANDA 089422

ANDA 089422

PAR PHARM

FDA Drug Application

Application #089422

Application Sponsors

ANDA 089422PAR PHARM

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL10MG0IMIPRAMINE HYDROCHLORIDEIMIPRAMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1987-07-14
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1988-08-19
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1988-08-19
LABELING; LabelingSUPPL6AP1991-01-07
LABELING; LabelingSUPPL7AP1993-11-05
LABELING; LabelingSUPPL8AP1995-10-23
LABELING; LabelingSUPPL9AP1996-03-25
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1996-03-25
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1996-03-25
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1997-10-02

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0

CDER Filings

PAR PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 89422
            [companyName] => PAR PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"IMIPRAMINE HYDROCHLORIDE","activeIngredients":"IMIPRAMINE HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"IMIPRAMINE HYDROCHLORIDE","submission":"IMIPRAMINE HYDROCHLORIDE","actionType":"10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.